KR100591857B1 - 안정성이 개선된 라미프릴 함유 약제학적 조성물 - Google Patents
안정성이 개선된 라미프릴 함유 약제학적 조성물 Download PDFInfo
- Publication number
- KR100591857B1 KR100591857B1 KR1020040040624A KR20040040624A KR100591857B1 KR 100591857 B1 KR100591857 B1 KR 100591857B1 KR 1020040040624 A KR1020040040624 A KR 1020040040624A KR 20040040624 A KR20040040624 A KR 20040040624A KR 100591857 B1 KR100591857 B1 KR 100591857B1
- Authority
- KR
- South Korea
- Prior art keywords
- ramipril
- weight
- pharmaceutical composition
- alginic acid
- starch
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Abstract
Description
성분명 | 1정당 중량(mg) | 중량% |
라미프릴 | 5.0 | 5.0 |
전분 | 2.5 | 2.5 |
유당 | 90.75 | 90.75 |
스테아린산마그네슘 | 1.75 | 1.75 |
정제수(휘발) | 10.0 | - |
계 | 100.0 | 100.0 |
성분명 | 1정당 중량(mg) | 중량% |
라미프릴 | 5.0 | 5.0 |
알긴산 | 1.0 | 1.0 |
유당 | 92.25 | 92.25 |
스테아린산마그네슘 | 1.75 | 1.75 |
정제수(휘발) | 20.0 | - |
계 | 100.0 | 100.0 |
성분명 | 1정당 중량(mg) | 중량% |
라미프릴 | 5.0 | 5.0 |
구아 검 | 0.5 | 0.5 |
유당 | 92.75 | 92.75 |
스테아린산마그네슘 | 1.75 | 1.75 |
정제수(휘발) | 20.0 | - |
계 | 100.0 | 100.0 |
성분명 | 1정당 중량(mg) | 중량% |
라미프릴 | 5.0 | 5.0 |
미결정셀룰로오스 | 50.0 | 50.0 |
유당 | 43.25 | 43.25 |
스테아린산마그네슘 | 1.75 | 1.75 |
계 | 100.0 | 100.0 |
실시예 1 | 실시예 2 | 실시예 3 | 비교예 1 | |
타정직후 함량 (%) | 99.1 | 99.4 | 99.3 | 99.4 |
타정시 압력 | 정제 경도 : 6∼8 kg/cm2 | |||
비고 | 습식 | 습식 | 습식 | 비처리 |
실시예 1 | 실시예 2 | 실시예 3 | 비교예 1 | |
가속(1개월) 후 함량 (%) | 99.0 | 98.6 | 98.9 | 96.2 |
가속(3개월) 후 함량 (%) | 98.4 | 98.3 | 98.5 | 93.1 |
가속(6개월) 후 함량 (%) | 97.9 | 97.8 | 97.7 | 88.3 |
타정시 압력 | 정제 경도 : 6∼8 kg/cm2 | |||
가속 조건 | 40℃, 75% RH | |||
비고 | 습식 | 습식 | 습식 | 비처리 |
실시예 1 | 실시예 2 | 실시예 3 | 비교예 1 | |
용출율 (%) | 91.5 | 84.0 | 86.2 | 95.6 |
용출기준 | 75% 이상 / 30 분 | |||
비고 | 습식 | 습식 | 습식 | 비처리 |
Claims (3)
- 라미프릴 함유 정제 조성물에 있어서,전체 중량 대비 5중량%의 라미프릴;유당; 스테아린산마그네슘; 정제수; 및전분, 알긴산 및 구아검에서 선택되는 적어도 1종의 화합물을 포함하고,상기에서 선택되는 적어도 1종의 화합물은 정제 전체 중량 대비 0.5~2.5중량%로 포함되는 것을 특징으로 하는 라미프릴 함유 정제 조성물.
- 제 1항에 있어서, 전체 중량 대비 5중량%의 라미프릴, 92.25중량%의 유당, 1.75중량%의 스테아린산마그네슘 및 1.0중량%의 알긴산으로 이루어진 라미프릴 함유 정제 조성물.
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040040624A KR100591857B1 (ko) | 2004-06-04 | 2004-06-04 | 안정성이 개선된 라미프릴 함유 약제학적 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040040624A KR100591857B1 (ko) | 2004-06-04 | 2004-06-04 | 안정성이 개선된 라미프릴 함유 약제학적 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050115533A KR20050115533A (ko) | 2005-12-08 |
KR100591857B1 true KR100591857B1 (ko) | 2006-06-23 |
Family
ID=37289432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040040624A KR100591857B1 (ko) | 2004-06-04 | 2004-06-04 | 안정성이 개선된 라미프릴 함유 약제학적 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100591857B1 (ko) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4975453A (en) * | 1988-05-28 | 1990-12-04 | Hoechst Aktiengesellschaft | Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals |
KR970004908A (ko) * | 1995-06-22 | 1997-01-29 | 김광호 | 칼라 텔레비젼 수상기의 색보정방법 및 장치 |
WO2002011709A2 (de) * | 2000-08-05 | 2002-02-14 | Hexal Ag | Pharmazeutische, ramipril enthaltende brauseformulierung |
-
2004
- 2004-06-04 KR KR1020040040624A patent/KR100591857B1/ko active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4975453A (en) * | 1988-05-28 | 1990-12-04 | Hoechst Aktiengesellschaft | Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals |
KR970004908A (ko) * | 1995-06-22 | 1997-01-29 | 김광호 | 칼라 텔레비젼 수상기의 색보정방법 및 장치 |
WO2002011709A2 (de) * | 2000-08-05 | 2002-02-14 | Hexal Ag | Pharmazeutische, ramipril enthaltende brauseformulierung |
Also Published As
Publication number | Publication date |
---|---|
KR20050115533A (ko) | 2005-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1341527B1 (en) | Pharmaceutical preparation comprising an active dispersed on a matrix | |
CA2424001C (en) | Oral preparations with favorable disintegration characteristics | |
US5358970A (en) | Pharmaceutical composition containing bupropion hydrochloride and a stabilizer | |
KR20010074914A (ko) | 오메프라졸 제형 | |
SK286625B6 (sk) | Farmaceutický prípravok na báze omeprazolu | |
KR20010024184A (ko) | 활성 성분으로 클로드로네이트, 부형제로 실리시파이드미세결정성 셀룰로즈를 함유하는 의약 제제 | |
RU2259828C2 (ru) | Способы стабилизации соединений на основе бензимидазола | |
WO2009102172A2 (ko) | 콜린 알포세레이트 함유 약학 제제 | |
US6558700B1 (en) | Multiple-unit sustained release tablets | |
JP4127740B2 (ja) | 安定化したベンズイミダゾール系化合物含有組成物 | |
KR100580855B1 (ko) | 안정화된 티볼론 조성물 | |
EP2500013B1 (en) | Pharmaceutical composition comprising solifenacin | |
JP4324260B2 (ja) | 医薬品調製物、その製造方法及びシランセトロンの安定化のための酸性添加剤の使用 | |
US6194002B1 (en) | Pharmaceutical composition comprising bupropion hydrochloride and fumaric acid | |
KR100591857B1 (ko) | 안정성이 개선된 라미프릴 함유 약제학적 조성물 | |
CN101754750A (zh) | 制备包含奥卡西平的控释固体制剂的方法及由所述方法可获得的制剂 | |
SK18582000A3 (sk) | Obalené cyklofosfamidové tablety | |
CN104758266B (zh) | 一种非洛地平缓释片及其制备工艺 | |
US6737419B2 (en) | Benazepril hydrochloride tablet formulations | |
CN110772490A (zh) | 一种阿哌沙班片剂的制备方法 | |
RU2377989C2 (ru) | Лекарственное средство триметазидина в форме матриксной таблетки с пролонгированным действием и способ его получения | |
CN1289077C (zh) | 一种马来酸曲美布汀片及其制备方法 | |
KR100841877B1 (ko) | 국소적으로 가용화 된 난용성 약물의 제어 방출형 제제조성물 및 그의 제조 방법 | |
EP0519371B1 (en) | Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions | |
EP3035919B1 (en) | Duloxetine enteric coated tablet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130905 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140516 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150712 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160524 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180523 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190411 Year of fee payment: 14 |